NCT06539520 Aerobic Training on Cardio-respiratory Fitness and Health Related Quality of Life
| NCT ID | NCT06539520 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Adly A Adam |
| Condition | Hemiplegia, Spastic |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2025-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-05-01 with a primary completion date of 2025-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Stroke is a major health problem among Egyptian population; an obvious raise in stroke prevalence in all Egyptian governorates. Most stroke survivors commonly develop disabilities those were correlated with restricted physical activity levels. Stroke survivors' cardio-respiratory fitness has several negative impacts such as elevated risk of being affected by other cardiovascular diseases. So, the current study will be conducted to cover the lack in literature concerning the effect of aerobic training on cardiovascular endurance in stroke survivors aiming to faster recovery and reduce the risk of cardiac dysfunction and recurrent strokes.
Eligibility Criteria
Inclusion Criteria: * Both genders, * Age range is 55-65 years old, * Within one year post ischemic stroke, * Right or left sided stroke, * hemiplegic and hemiparetic patients, * Medications include anti-spastics, Beta blockers, ACE inhibitors, and diuretics. * Functional ambulatory category of three or more, * Hemodynamic stable, * Did not participate in any other research study within at least 3 months. Exclusion Criteria: * Sever anemia, * Uncontrolled hypertension, or diabetes mellitus, * Recent cardiothoracic surgeries, * Cognitive disorders 'mini mental state exam less than 24' * Auditory and visual problems, * Dementia, * Modified Rankin score 3 or more, * Seizure, * Musculoskeletal disorders, * Stroke or serious head trauma within last 3 months, * Vertrobrobasilar stroke,
Contact & Investigator
Ali F Rahmy, PHD
STUDY DIRECTOR
Professor of Cardiovascular, Respiratory Disorders
Frequently Asked Questions
Who can join the NCT06539520 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, up to 65 Years, studying Hemiplegia, Spastic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06539520 currently recruiting?
Yes, NCT06539520 is actively recruiting participants. Contact the research team at info@pt.cu.edu.eg for enrollment information.
Where is the NCT06539520 trial being conducted?
This trial is being conducted at Giza, Egypt.
Who is sponsoring the NCT06539520 clinical trial?
NCT06539520 is sponsored by Adly A Adam. The principal investigator is Ali F Rahmy, PHD at Professor of Cardiovascular, Respiratory Disorders. The trial plans to enroll 80 participants.